• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Sanitas

Sanitas

  1. All
  2. 3rd Party
  1. Entasis Therapeutics and the Global Antibiotic Research & Development Partnership (GARDP) to Develop a New Treatment for Drug-Resistant Gonorrhea

    Entasis Therapeutics and the Global Antibiotic Research & Development Partnership (GARDP) to Develop a New Treatment for Drug-Resistant Gonorrhea

  2. UPDATE: How the stock market -- even near records -- shows the emptiness of Trump's bluster

    UPDATE: How the stock market -- even near records -- shows the emptiness of Trump's bluster

  3. Online Language Training Market in APAC 2017-2021 with Linguatronics, New Oriental Education & Technology, Rosetta Stone & Sanako Dominating - Research and Markets

    Online Language Training Market in APAC 2017-2021 with Linguatronics, New Oriental Education & Technology, Rosetta Stone & Sanako Dominating - Research and Markets

12

©2017 Morningstar Advisor. All right reserved.